Individuals with psoriasis/PsA have decreased ability to participate in social roles and activities, more depression symptoms

Pediatric patients likely to see pediatricians, dermatologists, emergency department staff, and family physicians before diagnosis

Improvement seen in total Skin Cancer Index score, all three subscale scores at 16 weeks after flap takedown versus before MMS

Individuals with psoriasis/PsA have decreased ability to participate in social roles and activities, more depression symptoms

Factors independently linked to development include atopic dermatitis, family history of psoriasis, skin and fungal infections

Prior therapy linked to lower objective response rate to adoptive cell transfer with tumor-infiltrating lymphocytes compared with no prior therapy

Incidence, prevalence, DALY, mortality rates higher for men every year since 1999; incidence, prevalence of melanoma higher in Northern U.S.

Risk for postoperative wound infection, complications, hemorrhage no greater with adalimumab versus placebo in hidradenitis suppurativa

Risk particularly heightened in the six months following diagnosis

Most sunburn encounters occur in the outpatient setting and are treated by a dermatologist or family medicine provider

2008 to 2018 saw increase from 49.7 to 62.9 percent in Black patients admitted with hidradenitis suppurativa diagnosis

Authors recommend that dermatologists perform a total-body skin examination even when a patient is referred for a suspicious lesion

Beta-HPV detected in skin swabs may predict cuSCC risk, but no link seen for serologic evidence of past beta-HPV infection

Men diagnosed at age 30 years or younger had a significantly lower mean number of children than those diagnosed at age 31 to 40,...

Overall response rate of 69.7 percent seen with topical HDAC inhibitor; complete resolution observed for 54.8 percent of tumors on pathologic exam

Single dose of REGEN-COV reduces symptomatic, asymptomatic infection risk in household contacts of infected persons for 28-day period

Controlled swelling linked to reduced risk; in subgroup analysis, risk increased with stage of edema

Upadacitinib demonstrated superior efficacy compared with dupilumab, was well tolerated in patients with moderate-to-severe atopic dermatitis

Controlled swelling linked to reduced risk; in subgroup analysis, risk increased with stage of edema

Odds for melanoma detection highest for presence of white structures, pseudopods, irregular pigmentation, blue-white veil, and peppering

Risk for bias high in papers relating to patients with psoriasis and psoriatic arthritis receiving biologic therapies

Facial rash with pustules seen on presentation, with leukocytosis with neutrophil predominance in two patients

≥75 percent improvement from baseline in Psoriasis Area and Severity Index was achieved by 78.8 percent at week 264